Targeting LINC00665/miR-199b-5p/SERPINE1 axis to inhibit trastuzumab resistance and tumorigenesis of gastric cancer via PI3K/AKt pathway

Long noncoding RNAs (lncRNAs) serve as critical mediators of tumor progression and drug resistance in cancer. Herein, we identified a lncRNA, LINC00665, associated with trastuzumab resistance and development in gastric cancer (GC). LINC00665 was highly expressed in GC tissues and high expression of...

Full description

Saved in:
Bibliographic Details
Main Authors: Bingyu Wang, Wenbo Liu, Buyun Song, Yong Li, Yingying Wang, Bibo Tan
Format: Article
Language:English
Published: KeAi Communications Co., Ltd. 2025-02-01
Series:Non-coding RNA Research
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2468054024001240
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850228055389241344
author Bingyu Wang
Wenbo Liu
Buyun Song
Yong Li
Yingying Wang
Bibo Tan
author_facet Bingyu Wang
Wenbo Liu
Buyun Song
Yong Li
Yingying Wang
Bibo Tan
author_sort Bingyu Wang
collection DOAJ
description Long noncoding RNAs (lncRNAs) serve as critical mediators of tumor progression and drug resistance in cancer. Herein, we identified a lncRNA, LINC00665, associated with trastuzumab resistance and development in gastric cancer (GC). LINC00665 was highly expressed in GC tissues and high expression of LINC00665 was correlated with poor prognosis. LINC00665 knockdown was verified to suppress migration, invasion, and resistance to trastuzumab in GC. Furthermore, we found that LINC00665 participates in the infiltration of naive B cells, mast cells, and T follicular helper (Tfh) cells. Mechanistically, LINC00665 was confirmed to regulate tumorigenesis and trastuzumab resistance by activating PI3K/AKt pathway. LINC00665 sponged miR-199b-5p to interact with SERPINE1 expression, resulting in the increase of phosphorylation of AKt, thus participating in the PI3K/AKt pathway. To summarize, LINC00665 facilitated the tumorigenesis and trastuzumab resistance of GC by sponging miR-199b-5p and promoting SERPINE1 expression, which further activated PI3K/AKt signaling; this finding reveals a new mechanism by which LINC00665 modulates tumor development and drug resistance in GC.
format Article
id doaj-art-7623c428cf084cd0bf63bbd2ebf4e380
institution OA Journals
issn 2468-0540
language English
publishDate 2025-02-01
publisher KeAi Communications Co., Ltd.
record_format Article
series Non-coding RNA Research
spelling doaj-art-7623c428cf084cd0bf63bbd2ebf4e3802025-08-20T02:04:38ZengKeAi Communications Co., Ltd.Non-coding RNA Research2468-05402025-02-011015316210.1016/j.ncrna.2024.07.004Targeting LINC00665/miR-199b-5p/SERPINE1 axis to inhibit trastuzumab resistance and tumorigenesis of gastric cancer via PI3K/AKt pathwayBingyu Wang0Wenbo Liu1Buyun Song2Yong Li3Yingying Wang4Bibo Tan5The Third Department of Surgery, The Fourth Hospital of Hebei Medical University, 050017, Shijiazhuang, ChinaThe Third Department of Surgery, The Fourth Hospital of Hebei Medical University, 050017, Shijiazhuang, ChinaThe Third Department of Surgery, The Fourth Hospital of Hebei Medical University, 050017, Shijiazhuang, ChinaThe Third Department of Surgery, The Fourth Hospital of Hebei Medical University, 050017, Shijiazhuang, ChinaThe Third Department of Surgery, The Fourth Hospital of Hebei Medical University, 050017, Shijiazhuang, ChinaCorresponding author.; The Third Department of Surgery, The Fourth Hospital of Hebei Medical University, 050017, Shijiazhuang, ChinaLong noncoding RNAs (lncRNAs) serve as critical mediators of tumor progression and drug resistance in cancer. Herein, we identified a lncRNA, LINC00665, associated with trastuzumab resistance and development in gastric cancer (GC). LINC00665 was highly expressed in GC tissues and high expression of LINC00665 was correlated with poor prognosis. LINC00665 knockdown was verified to suppress migration, invasion, and resistance to trastuzumab in GC. Furthermore, we found that LINC00665 participates in the infiltration of naive B cells, mast cells, and T follicular helper (Tfh) cells. Mechanistically, LINC00665 was confirmed to regulate tumorigenesis and trastuzumab resistance by activating PI3K/AKt pathway. LINC00665 sponged miR-199b-5p to interact with SERPINE1 expression, resulting in the increase of phosphorylation of AKt, thus participating in the PI3K/AKt pathway. To summarize, LINC00665 facilitated the tumorigenesis and trastuzumab resistance of GC by sponging miR-199b-5p and promoting SERPINE1 expression, which further activated PI3K/AKt signaling; this finding reveals a new mechanism by which LINC00665 modulates tumor development and drug resistance in GC.http://www.sciencedirect.com/science/article/pii/S2468054024001240Gastric cancerLong non-coding RNAPI3K/AKt signalingDrug resistanceTargeted therapyceRNA
spellingShingle Bingyu Wang
Wenbo Liu
Buyun Song
Yong Li
Yingying Wang
Bibo Tan
Targeting LINC00665/miR-199b-5p/SERPINE1 axis to inhibit trastuzumab resistance and tumorigenesis of gastric cancer via PI3K/AKt pathway
Non-coding RNA Research
Gastric cancer
Long non-coding RNA
PI3K/AKt signaling
Drug resistance
Targeted therapy
ceRNA
title Targeting LINC00665/miR-199b-5p/SERPINE1 axis to inhibit trastuzumab resistance and tumorigenesis of gastric cancer via PI3K/AKt pathway
title_full Targeting LINC00665/miR-199b-5p/SERPINE1 axis to inhibit trastuzumab resistance and tumorigenesis of gastric cancer via PI3K/AKt pathway
title_fullStr Targeting LINC00665/miR-199b-5p/SERPINE1 axis to inhibit trastuzumab resistance and tumorigenesis of gastric cancer via PI3K/AKt pathway
title_full_unstemmed Targeting LINC00665/miR-199b-5p/SERPINE1 axis to inhibit trastuzumab resistance and tumorigenesis of gastric cancer via PI3K/AKt pathway
title_short Targeting LINC00665/miR-199b-5p/SERPINE1 axis to inhibit trastuzumab resistance and tumorigenesis of gastric cancer via PI3K/AKt pathway
title_sort targeting linc00665 mir 199b 5p serpine1 axis to inhibit trastuzumab resistance and tumorigenesis of gastric cancer via pi3k akt pathway
topic Gastric cancer
Long non-coding RNA
PI3K/AKt signaling
Drug resistance
Targeted therapy
ceRNA
url http://www.sciencedirect.com/science/article/pii/S2468054024001240
work_keys_str_mv AT bingyuwang targetinglinc00665mir199b5pserpine1axistoinhibittrastuzumabresistanceandtumorigenesisofgastriccancerviapi3kaktpathway
AT wenboliu targetinglinc00665mir199b5pserpine1axistoinhibittrastuzumabresistanceandtumorigenesisofgastriccancerviapi3kaktpathway
AT buyunsong targetinglinc00665mir199b5pserpine1axistoinhibittrastuzumabresistanceandtumorigenesisofgastriccancerviapi3kaktpathway
AT yongli targetinglinc00665mir199b5pserpine1axistoinhibittrastuzumabresistanceandtumorigenesisofgastriccancerviapi3kaktpathway
AT yingyingwang targetinglinc00665mir199b5pserpine1axistoinhibittrastuzumabresistanceandtumorigenesisofgastriccancerviapi3kaktpathway
AT bibotan targetinglinc00665mir199b5pserpine1axistoinhibittrastuzumabresistanceandtumorigenesisofgastriccancerviapi3kaktpathway